Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2362962
Max Phase: Preclinical
Molecular Formula: C36H45F4N3O6S
Molecular Weight: 723.83
Molecule Type: Small molecule
Associated Items:
ID: ALA2362962
Max Phase: Preclinical
Molecular Formula: C36H45F4N3O6S
Molecular Weight: 723.83
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@@H]1CCCCO[C@H](CN(C)Cc2ccc(C(F)(F)F)cc2)[C@H](C)CN([C@H](C)CO)C(=O)c2cc(NS(=O)(=O)c3ccc(F)cc3)ccc2O1
Standard InChI: InChI=1S/C36H45F4N3O6S/c1-24-20-43(25(2)23-44)35(45)32-19-30(41-50(46,47)31-15-12-29(37)13-16-31)14-17-33(32)49-26(3)7-5-6-18-48-34(24)22-42(4)21-27-8-10-28(11-9-27)36(38,39)40/h8-17,19,24-26,34,41,44H,5-7,18,20-23H2,1-4H3/t24-,25-,26-,34-/m1/s1
Standard InChI Key: UQRVVYXDOOLUAO-CZWSTMTISA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 723.83 | Molecular Weight (Monoisotopic): 723.2965 | AlogP: 6.57 | #Rotatable Bonds: 9 |
Polar Surface Area: 108.41 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 9 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 7.78 | CX Basic pKa: 8.39 | CX LogP: 5.34 | CX LogD: 5.07 |
Aromatic Rings: 3 | Heavy Atoms: 50 | QED Weighted: 0.24 | Np Likeness Score: -0.96 |
1. PubChem BioAssay data set, |
Source(1):